65,437 trials
Esophageal Cancer
Primary: Number of Participants With Overall Response Rate (RR) — 44 participants
Glioblastoma Multiforme · Astrocytoma
Primary: Percentage of Participants With Progression Free Survival (PFS) During the Study Duration — 5.3; 6.6; 2.1; 2.1 Percentage of Participants
Human Immunodeficiency Virus Infection
Primary: Percentage of Participants Responding (Plasma HIV-1 Ribonucleic Acid [RNA] Levels Less Than 40 Copies/Milliliter [mL]) at Week 48 Based on the Food and Drug…
Post Acute Coronary Syndrome · Myocardial Ischemia
Primary: Change From Baseline in N-terminal proB-type Natriuretic Peptide (NT-proBNP) at Week 8 — 0.582; 0.563; 0.614; 0.635 pg/mL
Hypertension
Primary: Change in Mean Sitting Diastolic Blood Pressure (msDBP) During the Core Phase of the Study — -3.12 mmHg
Influenza
Primary: Influenza Vaccine Coverage (Percent) for New Mothers of Newborns — 70; 64 Percentage of Participants
Kidney Diseases · Coronary Artery Disease
Primary: Number of Subject With Serious Treatment Emergent Adverse Events (TEAE) — 0; 0 Subjects
Anxiety · Depression
Primary: Hospital Anxiety and Depression Scale - Depression Scale at Baseline — 4.70; 7.47; 5.35; 4.12 units on a scale
Human Experimentation
Primary: Achievement of Sustained Difference in Inhibition of Intragastric Acidity Based on Median pH Values Between the Two Active Study Treatments at Steady-state on Day 7…
Atopic Dermatitis
Primary: Change in Eczema Area Severity Index (EASI) Score From Baseline (Week 1) to Week 16. — 26.4 Scores on a scale.
Migraine
Primary: Pain Relief (PR) — 105; 21; 88; 72 Attacks — p=<0.001
Influenza
Primary: Antibody Responses According to the Hemagglutinin Inhibition (HI) Assay After the First and Second Vaccinations — 11; 9; 13; 11 percentage of subjects
Uveitis · Macular Edema
Primary: Number of Participants With Systemic Toxicities, Adverse Events, or Infections — 6 Participants
Pain · Inflammation
Primary: Summed Ocular Inflammation Score (SOIS) of Zero — 70; 36 participants
Type 2 Diabetes
Primary: Change in Glycosylated Hemoglobin (HbA1c) — -1.71; -1.00 percentage of hemoglobin — p=<0.001